Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -51.60x is 25% below its 1-year average of -41.13x, near the low end of its 1-year range (-51.60x–-30.66x).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-51.60x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-709.33%
vs the sector median at left
Maze Therapeutics, Inc.
Market Cap
$1.46B
Interest Coverage Ratio
-51.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.48B
Interest Coverage Ratio
-131.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.45B
Interest Coverage Ratio
30.72x
TTM Avg
19.49x
3Y Avg
15.15x
5Y Avg
21.38x
Market Cap
$1.44B
Interest Coverage Ratio
1.06x
TTM Avg
1.06x
3Y Avg
1.45x
5Y Avg
1.23x
Market Cap
$1.48B
Interest Coverage Ratio
4.17x
TTM Avg
3.75x
3Y Avg
3.48x
5Y Avg
4.61x
Market Cap
$1.49B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.50B
Interest Coverage Ratio
0.02x
TTM Avg
0.02x
3Y Avg
0.02x
5Y Avg
0.02x
Market Cap
$1.42B
Interest Coverage Ratio
-8.63x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.50B
Interest Coverage Ratio
12.40x
TTM Avg
9.47x
3Y Avg
9.47x
5Y Avg
17.56x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | $1.46B | -51.60x | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.48B | -131.05x | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 30.72x | 19.49x | 15.15x | 21.38x |
| Certara, Inc. (CERT)vs › | $1.44B | 1.06x | 1.06x | 1.45x | 1.23x |
| Phibro Animal Health Corporation (PAHC)vs › | $1.48B | 4.17x | 3.75x | 3.48x | 4.61x |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.49B | N/A | N/A | N/A | N/A |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 0.02x | 0.02x | 0.02x | 0.02x |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.42B | -8.63x | N/A | N/A | N/A |
| Nutex Health, Inc. (NUTX)vs › | $1.50B | 12.40x | 9.47x | 9.47x | 17.56x |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 0.60x | 0.60x | 0.60x | 0.60x |
Interest Coverage
-51.6x
Debt/Equity
0.13
Current Ratio
18.31
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -51.60x |
| 2026-03-31 | -30.66x |
